Clin2
NCT04806620Possibly a fitRecruiting

Online app study for brain inflammation lifestyle data

Post-Acute COVID-19 SyndromeME/CFSRheumatic ArthritisJuvenile Rheumatoid Arthritis (JRA)Psoriatic Arthritis (PsA)Ankylosing Spondylitis (AS)Autoimmune EncephalitisCeliac Disease

Part of Blood & lymphatic, Bones, joints & muscles, Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections, Injuries & trauma, Lungs & breathing, Mental health, Skin, Women’s health & pregnancy clinical trials.

This study uses a digital platform (app/website) to collect lifestyle and symptom information to better understand brain inflammation. You may qualify if you have certain conditions like Long COVID, migraines, autoimmune disease, inflammatory gut issues, mood disorders, or if you are a healthy comparison person.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
2 years and older
Study type
Observational

Who can take part

  • You live in the United States
  • You can complete surveys in English
  • You have steady internet access and a phone, tablet, or computer
  • You are willing to share your symptom and health data through the app
  • You have one of these types of conditions (or are a healthy comparison person): brain inflammation–related illness, autoimmune disease, inflammatory gut disease, or certain mood/behavior conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06366724Recruiting· Phase 2
Life Improvement Trial for ME/CFS

This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.

Boston, Massachusetts
NCT07783074Recruiting
Fatigue study using digital outcomes in multiple sclerosis and long COVID

This study is investigating fatigue using digital outcomes in people with multiple sclerosis, long COVID, and healthy volunteers. Participants must own a smartphone, be fluent in German or English, and be willing to provide informed consent. Exclusion criteria include having taken certain medications recently, being pregnant or lactating, or having additional health conditions that could affect fatigue or the autonomic nervous system.

Basel, Basel
NCT05670301Recruiting
Blood test study to profile inflammation biomarkers in diseases

This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.

Antwerp
NCT07150000Recruiting
Rheumatic disease research study for patients and healthy volunteers

This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.

Bonn, North Rhine-Westphalia
NCT05741112Recruiting
Long COVID wearable study to track symptoms and help daily management

This study uses a wearable device to track symptoms and patterns in people with Long COVID, ME/CFS, and/or POTS. The goal is to see how wearable feedback and tracking tools may help you manage your symptoms.

La Jolla, California
NCT00794352Recruiting
Studying immune brain and nerve conditions with tests and samples

This study looks at how immune-related brain or spinal cord illness shows up using exams, MRI scans, and sometimes a spinal fluid test (lumbar puncture), plus collected blood and other samples. It may help researchers better understand these conditions and improve future diagnosis or treatments.

Bethesda, Maryland

Hear when a new Post-Acute COVID-19 Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.